These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26292875)

  • 1. Re: Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Total Serum Testosterone Level in Healthy Middle-Aged Eugonadal Men.
    Kaplan SA
    J Urol; 2015 Sep; 194(3):734-5. PubMed ID: 26292875
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Otunctemur A; Ozbek E; Besiroglu H; Dursun M; Sahin S; Koklu I; Erkoc M; Danis E; Bozkurt M; Gurbuz A
    Int J Urol; 2014 Dec; 21(12):1268-72. PubMed ID: 25056570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: a new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Atala A
    J Urol; 2013 Aug; 190(2):807. PubMed ID: 23845375
    [No Abstract]   [Full Text] [Related]  

  • 5. [Association of lower urinary tract symptoms and testosterone deficiency in men with type 2 diabetes].
    Kogan MI; Belousov II; Ibishev HS; Cherniy AA; Khripun IA; Vorobyev SV; Sizjakin DV
    Urologiia; 2016 Dec; (6):22-26. PubMed ID: 28248039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
    McVary KT; Peterson A; Donatucci CF; Baygani S; Henneges C; Clouth J; Wong D; Oelke M
    J Urol; 2016 Sep; 196(3):824-30. PubMed ID: 27105760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of low testosterone and its relationship to body mass index in older men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Kaplan SA; Lee JY; O'Neill EA; Meehan AG; Kusek JW
    Aging Male; 2013 Dec; 16(4):169-72. PubMed ID: 24134648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
    J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: The Role of Inflammation in Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) and its Potential Impact on Medical Therapy.
    Kaplan SA
    J Urol; 2016 Mar; 195(3):689-90. PubMed ID: 26887734
    [No Abstract]   [Full Text] [Related]  

  • 10. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
    Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
    J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
    Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
    Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
    Daniels JP; Mirocha J; Adjei M; Moreira D; Freedland SJ
    J Urol; 2024 Jan; 211(1):101-110. PubMed ID: 37873943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Reasons for prescription change of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2015 Apr; 193(4):1317. PubMed ID: 25890537
    [No Abstract]   [Full Text] [Related]  

  • 15. Testosterone and the Prostate: Artifacts and Truths.
    DeLay KJ; Kohler TS
    Urol Clin North Am; 2016 Aug; 43(3):405-12. PubMed ID: 27476133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Newer and older drugs do not differ for lower urinary tract symptoms due to benign prostatic hyperplasia.
    Foldes C; Canfield SE
    Ann Intern Med; 2016 Oct; 165(8):JC45. PubMed ID: 27750305
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment from Dr Zampieri to Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Zampieri N
    Int J Urol; 2014 Dec; 21(12):1272-3. PubMed ID: 25115742
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial Comment from Dr Li to Is the presence of varicocele associated with static and dynamic components of benign prostatic hyperplasia/lower urinary tract symptoms in elderly men?
    Li F
    Int J Urol; 2014 Dec; 21(12):1272. PubMed ID: 25115707
    [No Abstract]   [Full Text] [Related]  

  • 19. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment.
    Mobley D; Feibus A; Baum N
    Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.
    McVary KT; Roehrborn CG; Chartier-Kastler E; Efros M; Bugarin D; Chen R; Patel A; Haag-Molkenteller C
    J Urol; 2014 Jul; 192(1):150-6. PubMed ID: 24508634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.